Thomas Woiwode, Director at CRISPR Therapeutics AG (CRSP), sold 291,361 shares at $51.00 ($10.1M) on 2018-04-23, disclosed to the SEC on 2018-04-24.
Open-market sale of $10.1M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 92,918 | $0 | 0.0% |
| 2 | $50.66 | 6,821 | $346K | 3.4% |
| 3 | $50.66 | 89,628 | $4.5M | 45.2% |
| 4 | $50.66 | 89,628 | $4.5M | 45.2% |
| 5 | $50.66 | 6,821 | $346K | 3.4% |
| 6 | $51.00 | 2,915 |
| $149K |
| 1.5% |
| 7 | $51.00 | 2,630 | $134K | 1.3% |
| Total | $34.51 avg | 291,361 | $10.1M | 100% |
| Filing → |
| ALGS | BUY | 2020-10-20 | $3.0M | — | Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |
| CRSP | SELL | 2018-05-17 | $2.6M | — | Filing → |